Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024

EXAIDelisted Stock  USD 4.84  0.00  0.00%   
Under 56% of Exscientia's investor base is looking to short. The analysis of overall sentiment of trading Exscientia Ltd ADR stock suggests that many investors are alarmed at this time. Exscientia's investing sentiment shows overall attitude of investors towards Exscientia Ltd ADR.
  
Exscientia plc today announced three abstracts to be presented at the 36th EORTC-NCI-AACR Symposium 2024 from October 23-25, in B

Read at businesswire.com
businesswire News
  

Exscientia Fundamental Analysis

We analyze Exscientia's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Exscientia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Exscientia based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

Exscientia is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Exscientia ADR Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Exscientia stock to make a market-neutral strategy. Peer analysis of Exscientia could also be used in its relative valuation, which is a method of valuing Exscientia by comparing valuation metrics with similar companies.

Peers

Exscientia Related Equities

GLUEMonte Rosa   13.72   
0%
100.0%
RXRXRecursion Pharmaceuticals   10.82   
0%
78.0%
SANASana Biotechnology   9.02   
0%
65.0%
IPSCCentury Therapeutics   5.52   
0%
40.0%
ELEVElevation Oncology   3.23   
0%
23.0%
UBXUnity Biotechnology   2.48   
0%
18.0%
LPTXLeap Therapeutics   2.05   
0%
14.0%
PDSBPDS Biotechnology   1.86   
0%
13.0%
ZURAZura Bio   1.67   
0%
12.0%
MREOMereo BioPharma   1.40   
0%
10.0%
BPMCBlueprint Medicines   1.35   
0%
9.0%
KYMRKymera Therapeutics   0.02   
1.0%
0%
AVIRAtea Pharmaceuticals   1.16   
8.0%
0%
RVMDRevolution Medicines   1.25   
9.0%
0%
ADAPAdaptimmune Therapeutics   1.37   
9.0%
0%
RLAYRelay Therapeutics   2.08   
15.0%
0%
PIRSPieris Pharmaceuticals   3.45   
25.0%
0%
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Exscientia Stock

If you are still planning to invest in Exscientia ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exscientia's history and understand the potential risks before investing.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency